Article Text

Download PDFPDF
Neurodevelopmental treatment after stroke: a comparative study
  1. T B Hafsteinsdóttir1,
  2. A Algra2,
  3. L J Kappelle3,
  4. M H F Grypdonck4,
  5. on behalf of the Dutch NDT Study Group*
  1. 1Rudolph Magnus Institute of Neurosciences, Department of Neurology, and Julius Centre for Health Sciences and Primary Care, Department of Nursing Sciences, University Medical Centre Utrecht, Utrecht, Netherlands
  2. 2Julius Centre for Health Sciences and Primary Care, Department of Clinical Epidemiology, and Rudolph Magnus Institute of Neurosciences, Department of Neurology, University Medical Centre Utrecht
  3. 3Rudolph Magnus Institute of Neurosciences, Department of Neurology, University Medical Centre Utrecht
  4. 4Julius Centre for Health Sciences and Primary Care, Department of Nursing Sciences, University Medical Centre Utrecht
  1. Correspondence to:
 Dr Ale Algra
 Department of Neurology and Julius Centre, University Medical Centre Utrecht, STR 6.131, PO Box 85500, 3508 GA Utrecht, Netherlands; A.Algraumcutrecht.nl

Abstract

Background: Neurodevelopmental treatment (NDT) is a rehabilitation approach increasingly used in the care of stroke patients, although no evidence has been provided for its efficacy.

Objective: To investigate the effects of NDT on the functional status and quality of life (QoL) of patients with stroke during one year after stroke onset.

Methods: 324 consecutive patients with stroke from 12 Dutch hospitals were included in a prospective, non-randomised, parallel group study. In the experimental group (n = 223), nurses and physiotherapists from six neurological wards used the NDT approach, while conventional treatment was used in six control wards (n = 101). Functional status was assessed by the Barthel index. Primary outcome was “poor outcome”, defined as Barthel index <12 or death after one year. QoL was assessed with the 30 item version of the sickness impact profile (SA-SIP30) and the visual analogue scale.

Results: At 12 months, 59 patients (27%) in the NDT group and 24 (24%) in the non-NDT group had poor outcome (corresponding adjusted odds ratio = 1.7 (95% confidence interval, 0.8 to 3.5)). At discharge the adjusted odds ratio was 0.8 (0.4 to 1.5) and after six months it was 1.6 (0.8 to 3.2). Adjusted mean differences in the two QoL measures showed no significant differences between the study groups at six or 12 months after stroke onset.

Conclusions: The NDT approach was not found effective in the care of stroke patients in the hospital setting. Health care professionals need to reconsider the use of this approach.

  • CES-D, Center of Epidemiological Studies depression scale
  • MMSE, mini-mental state examination
  • NDT, neurodevelopmental treatment
  • QoL, quality of life
  • SA-SIP30, stroke adapted 30 item version of the sickness impact profile
  • neurodevelopmental treatment
  • nursing
  • rehabilitation
  • stroke

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: none declared